Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind phase IV comparison of monovalent type 1 oral poliomyelitis vaccine versus trivalent oral poliomyelitis vaccine in newborn infants
ISRCTN54186735Phase 4Completed
- Sponsor
- Panacea Biotec
- Start
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised, double-blind trial of monovalent oral polio vaccine type 1 and trivalent oral poliovirus vaccine in poliomyelitis (4 arms), sponsored by Panacea Biotec. Started Sep 2007; status: completed.
02
Drugs
monovalent oral polio vaccine type 1trivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ISRCTN54186735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54186735.